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Abstract
OBJECTIVES—Heritable and environmental factors may contribute to differences in colorectal 
cancer (CRC) incidence across populations. We capitalized on the resources of the California 
Cancer Registry (CCR) and California’s diverse Asian population to perform a cohort study 
exploring the relationships between CRC incidence, nativity, and neighborhood-level factors 
across Asian subgroups.
METHODS—We identified CRC cases in the CCR from 1990 to 2004 and calculated age-
adjusted CRC incidence rates for non-Hispanic Whites and US-born vs. foreign-born Asian ethnic 
subgroups, stratified by neighborhood socioeconomic status (SES) and “ethnic enclave.” Trends 
were studied with joinpoint analysis.
RESULTS—CRC incidence was lowest among foreign-born South Asians (22.0/100,000; 95% 
confidence interval (CI): 19.7–24.5/100,000) and highest among foreign-born Japanese 
(74.6/100,000; 95% CI: 70.1–79.2/100,000). Women in all Asian subgroups except Japanese, and 
men in all Asian subgroups except Japanese and US-born Chinese, had lower CRC incidence than 
non-Hispanic Whites. Among Chinese men and Filipino women and men, CRC incidence was 
lower among foreign-born than US-born persons; the opposite was observed for Japanese women 
and men. Among non-Hispanic Whites, but not most Asian subgroups, CRC incidence decreased 
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over time. CRC incidence was inversely associated with neighborhood SES among non-Hispanic 
Whites, and level of ethnic enclave among Asians.
CONCLUSIONS—CRC incidence rates differ substantially across Asian subgroups in 
California. The significant associations between CRC incidence and nativity and residence in an 
ethnic enclave suggest a substantial effect of acquired environmental factors. The absence of 
declines in CRC incidence rates among most Asians during our study period may point to 
disparities in screening compared with Whites.
INTRODUCTION
Colorectal cancer (CRC) incidence varies between countries and subpopulations within 
countries (1–3). Heritable and environmental factors may each account for some of these 
differences (4). Screening substantially decreases CRC incidence and mortality (5–9), and 
probably has contributed to recent decreases in US CRC incidence (4,10,11).
Persons of Asian ancestry in the United States are a heterogenous population, representing 
many countries of origin, birthplace in Asia or the United States, and varying degrees of 
acculturation to a “Western” lifestyle (12,13). Epidemiological analyses that consider Asians 
as a single group may obscure important differences between subgroups (14). Studies of 
immigrants, including studies of CRC risk in Japanese compared with Japanese immigrants 
and their descendants in Hawaii and California (15–17), represent classic epidemiological 
studies of the environment’s impact on cancer risk. The large and diverse Asian population 
in California and the resources of the California Cancer Registry (CCR) (18–22) provide a 
unique opportunity to further examine the relative burden of CRC in Asian American 
subpopulations, and the possible role of environmental factors.
We examined differences in CRC incidence, tumor characteristics, and trends over time 
among the major Asian subgroups in California and evaluated the impact of nativity, 
neighborhood socioeconomic status (SES), and residence on an ethnic enclave (19–22). We 
hypothesized that lower CRC incidence rates would be observed among foreign-born Asians 
vs. US-born Asians, and among those living in ethnic enclaves, where Western lifestyles 
might be less prevalent vs. those living in the least ethnic neighborhoods.
METHODS
CRC incidence data
CRC cases were identified using the CCR (18), which comprise four National Cancer 
Institute SEER (Surveillance, Epidemiology, and End Results) program registries (23). We 
obtained information on all California residents diagnosed with a primary invasive colon or 
rectal cancer (International Classification of Disease for Oncology, 3rd Edition, C180–189, 
C260, C199, C209, and excluding histologies 9,590–9,989, 9,050–9,055, and 9,140) from 1 
January 1990 through 31 December 2004. At the time of analysis, the required Census 2010 
data by ethnicity and nativity were not available to produce population estimates beyond 
2004. Tumor location was categorized as proximal colon, distal colon, rectum, or other. Our 
cohort includes 16,159 Asians (5,645 Chinese, 3,506 Japanese, 3,921 Filipino, 1,389 
Korean, 453 South Asian (including Asian Indian, Pakistani, Sri Lankan, and Bangladeshi), 
Ladabaum et al. Page 2
Am J Gastroenterol. Author manuscript; available in PMC 2017 December 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
and 1,244 Vietnamese), and 153,804 non-Hispanic Whites as a comparison group. These six 
Asian ethnic populations comprised 92.5% of all Asian and Pacific Islander patients with 
CRC in the CCR in 1990–2004.
Nativity data
Registry-based birthplace data were available for 83% of cases (69% from hospital records; 
14% from death certificates). As Asian patients in the CCR with unknown birthplace are 
more likely to be US born (24,25), we applied our previously validated statistical imputation 
method (14) based on Social Security numbers (SSN) to classify nativity into US born or 
foreign born. This method considers cases who received a SSN before the age of 25 years as 
US born, and the rest as foreign born, resulting in 84% sensitivity and 80 % specificity 
across each Asian population (14). We used this approach for 16% of cases with unknown 
birthplace. The 1% of cases with missing or invalid SSNs were randomly assigned an 
immigrant status based on the overall sample’s ethnicity-sex-age-birthplace distribution. The 
numbers of US-born South Asian (45), Vietnamese (44), and Korean (54) cases were too 
small for analyses.
Population data for cancer rate denominators
From the 1990 and 2000 Census Summary File 3, we obtained population counts by sex, 
race/ethnicity, immigrant status, and 5-year age group for California. We used the 5% 
Integrated Public Use Microdata Sample of the Census to estimate age- and birthplace-
specific population counts for the six Asian groups (26–29) by smoothing with a spline-
based function (30). For intercensal years, we estimated the percent foreign-born using 
cohort component interpolation and extrapolation methods (31), adjusting estimates to the 
populations by age and year provided by the US Census for 1990–2004.
Incidence rates by neighborhood socioeconomic and ethnic enclave status
Using patient residential address and small area (census tract) information from the US 
Census, we classified neighborhood SES and ethnic enclave status (19–22) for all Asian 
patients diagnosed with CRC between 1 January 1998 and 31 December 2002. For these 
analyses, we grouped all Asians and Pacific Islanders together into a single group because 
detailed ethnicity-specific population estimates are not available for census tracts, and we 
chose 1998–2002 (i.e., within 2 years of the 2000 US Census) because census tract-level 
population estimates by race/ethnicity are only available for decennial census years. For 
CRC cases, census tracts were geocoded from residential addresses at the time of diagnoses. 
The 3% of cases whose address could not be precisely geocoded were randomly assigned to 
a census tract within their county of residence. We assigned neighborhood SES using a 
previously described (32) and widely used index that incorporates 2000 US Census data on 
education, income, occupation, and housing costs based on selection via principal 
components analysis. We categorized this measure by quintiles based on the distribution of 
the composite SES index across California. As the CCR does not collect individual-level 
SES information, we could not assess this separately from neighborhood-level effects.
We defined a neighborhood ethnic enclave as a geographical unit that is relatively more 
concentrated than other units in California with respect to population and language (here, 
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specific to Asians) (21). To characterize residence in an ethnic enclave, we applied principal 
components analysis to selected census variables at the block group level, which was in turn 
averaged to the census tract level. The variables included in the ethnic enclave index were 
percent of Asian language-speaking households that are linguistically isolated (as defined by 
the Census: household in which all adults (aged 14 or older) speak an Asian language and 
none speaks English “very well”), percent of all Asian language speakers who speak limited 
English, percent of recent immigrants, and percent of Asian. This index explained 63% of 
the variability in the data. Neighborhood ethnic enclave was classified into quintiles based 
on the distribution of the composite ethnic enclave index across California.
Statistical analysis
Cancer incidence rates and 95% confidence intervals (CIs) were calculated as cases per 
100,000 persons and age adjusted to the 2000 US standard population using SEER⋆Stat 
software (http://www.seer.cancer.gov/seerstat/). To comply with CCR confidentiality 
regulations, we do not present counts or rates based on less than five cases. We calculated 
incidence rates for populations defined by race/ethnicity, sex, nativity, and/or neighborhood 
characteristics. To compare rates between groups, we computed incidence rate ratios and 
their associated 95% CIs and P values, with exclusion of 1 in the 95% CI reflecting an 
incidence rate ratio that differs significantly from 1 at P < 0.05. As neighborhood SES and 
ethnic enclave status are highly correlated, we also defined census tracts jointly by SES and 
ethnic enclave. We could not perform joint analyses by patient-level birthplace and 
neighborhood SES or ethnic enclave status owing to the lack of census-tract-level population 
data by birthplace. Distributions of CRC cases were compared with χ2-tests. Joinpoint 
regression models and annual percentage change statistics were used to characterize the 
magnitude, direction, and duration of trends (33). A maximum of two joinpoints were 
selected a priori based on the numbers of years of data available. All analyses had the 
approval of the Institutional Review Board of the Cancer Prevention Institute of California.
RESULTS
Patient demographics and tumor characteristics
The demographic and tumor characteristics of CRC patients are shown in Table 1 for non-
Hispanic Whites and Asian subgroups by race/ethnicity and nativity. Proximal colon cancer 
was proportionally more common among non-Hispanic Whites (42.2%) than among the 
Asian subgroups (24.8–33.9%; P < 0.0001 for all pairwise comparisons). Localized CRC 
was proportionally more common among non-Hispanic Whites (37.3%) than among all 
foreign-born Asian subgroups (30.2–32.9%; P < 0.001 for all pairwise comparisons). In 
contrast, the proportions of localized CRC did not differ significantly between non-Hispanic 
Whites and US-born Chinese (P = 0.18), US-born Japanese (P = 0.26), and US-born Filipino 
(P = 0.25). US-born Chinese and foreign-born South Asian patients with CRC were more 
likely to live in the highest SES neighborhoods than non-Hispanic Whites and other Asian 
subgroups, whereas foreign-born Chinese, Filipino, Korean, and Vietnamese patients with 
CRC were more likely to live in the lowest two SES quintile neighborhoods (Table 1).
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CRC incidence
Age-adjusted incidence rates of invasive CRC differed by Asian subgroup, sex, and nativity 
(Table 2). Foreign-born South Asians had the lowest (22.0/100,000; 95% CI: 19.7–
24.5/100,000) and foreign-born Japanese had the highest (74.6/100,000; 95% CI: 70.1–
79.2/100,000) CRC incidence rates. Men had higher CRC incidence than women in all 
subgroups. Compared with non-Hispanic White women, women in all Asian subgroups 
except Japanese had lower CRC incidence. Compared with non-Hispanic White men, men in 
all Asian subgroups except Japanese and US-born Chinese had lower CRC incidence.
Foreign-born Chinese men had lower CRC incidence than US-born Chinese men, but there 
was no significant difference between foreign-born and US-born Chinese women. CRC 
incidence was higher in foreign-born Japanese women and men than in US-born Japanese 
women and men, and lower in foreign-born Filipino women and men than in US-born 
Filipino women and men.
Trends in CRC incidence
Among non-Hispanic White women and men, CRC incidence rates decreased significantly 
over time, but such decreases were not observed among most Asian subgroups (Table 3; 
Figures 1 and 2).
Among non-Hispanic White women, CRC incidence decreased annually by 2.1% (95% CI: 
0.8–3.4%) from 1990 to 1995, did not change significantly from 1995 to 1998, and 
decreased annually by 2.4% (95% CI: 1.4–3.4%) from 1998 to 2004. Among non-Hispanic 
White men, CRC incidence decreased annually by 2.5% (95% CI: 1.3–3.7%) from 1990 to 
1995, did not change significantly from 1995 to 1998, and decreased annually by 2.7% (95% 
CI: 1.8–3.6%) from 1998 to 2004.
The only Asian subgroups in which CRC incidence changed significantly over time were 
foreign-born Chinese men, in whom CRC incidence decreased annually by 1.5% (95% CI: 
0.6–2.4%) from 1990 to 2004, and US-born Japanese men, in whom CRC incidence 
increased annually by 4.2 % (95 % CI: 0.2–8.5 %) from 1990 to 1997, and then decreased 
annually by 4.5% (95% CI: 1.3–7.6%) from 1997 to 2004.
Incidence patterns by neighborhood SES and ethnic enclave
Among non-Hispanic Whites, CRC incidence rate was inversely associated with census tract 
level SES quintile (Table 4). CRC incidence was 47.9/100,000 (95% CI: 47.1–48.8/100,000) 
in the highest SES quintile compared with 69.3/100,000 (95% CI: 67.4–71.2/100,000) in the 
lowest SES quintile (incidence rate ratio: 0.69, 95% CI: 0.67–0.71). In contrast, among 
Asians/Pacific Islanders, an inconsistent association was seen, with relatively lower rates 
among the second and lowest SES quintiles (Table 4).
Among Asians/Pacific Islanders, CRC incidence was inversely associated with census tract 
ethnic enclave level (Table 4). CRC incidence was 43.2/100,000 (95% CI: 41.4–
44.6/100,000) in the highest ethnic enclave quintile (most ethnic) compared with 
53.8/100,000 (95% CI: 46.9–61.4/100,000) in the lowest ethnic enclave quintile (least 
ethnic; incidence rate ratio: 0.80, 95% CI: 0.70–0.92).
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The effect of census tract level ethnic enclave was seen in higher as well as lower SES 
levels, but was more pronounced in the two highest SES quintiles (Table 4). CRC incidence 
was lowest among persons living in high SES and high ethnic enclave neighborhoods 
(42.7/100,000; 95% CI: 40.9–44.4/100,000), and highest among persons living in high SES 
and low ethnic enclave neighborhoods (53.2/100,000; 95% CI: 49.4–57.2/100,000).
DISCUSSION
We found substantial differences in CRC incidence among Asian subgroups in California, 
with a threefold incidence rate difference between foreign-born South Asians, who had the 
lowest CRC incidence, and foreign-born Japanese, who had the highest. Compared with 
non-Hispanic Whites, Asians were more likely to present with distal CRC, foreign-born 
Asians were less likely to present with localized disease, and all subgroups except Japanese 
and US-born Chinese men had lower CRC incidence. The relationship between CRC 
incidence and nativity varied among Asian subgroups. In contrast with the significant 
decrease in CRC incidence over time that was observed among non-Hispanic Whites during 
our study period, CRC incidence did not decline significantly among most Asian subgroups. 
The direct relationship between SES and CRC incidence that was observed among non-
Hispanic Whites was not observed in Asians. Instead, among Asians, residence in an ethnic 
enclave was directly associated with decreased CRC incidence, and it modified the 
relationship with neighborhood SES.
Previous studies have shown that invasive CRC incidence rates are usually but not always 
higher among Asian-Americans than in Asia (34,35). This general pattern is consistent with 
our observation of significantly higher CRC rates among US-born Filipinos and US-born 
Chinese men relative to their foreign-born counterparts, but is not consistent with our 
observations of similar rates between US-born and foreign-born Chinese women, and higher 
rates among foreign-born than US-born Japanese women and men. Earlier studies of 
Japanese migrants to Hawaii have shown higher CRC incidence rates among first- and 
second-generation migrants than among Japanese in Japan (16). First-generation Japanese 
migrants quickly reached the high incidence rates of CRC among Whites in Hawaii, 
indicating environmental risk factors may operate later in life (16). Our findings confirm 
past observations of substantially higher rates in foreign-born Japanese than Non-Hispanic 
Whites (74.6 vs. 52.8 per 100,000, respectively, in our study). Our results are in line with 
those of some (16) but not all (34) previous studies. In the latter study, unknown birthplace 
was imputed assuming the distribution for cases with known birthplace, which may bias the 
estimates. To lend additional perspective to our findings, invasive CRC incidence rates 
among African-Americans in California from 1990 to 2004 were higher than for most Asian 
subgroups (71.5 per 100,000 among men, and 55.4 per 100,000 among women) (36).
Acculturation generally results in higher prevalence of CRC risk factors, such as obesity and 
physical inactivity (12,13), and increased intake of red and processed meats and refined 
grains, and decreased intake of fruits, vegetables, and whole grains (37). However, screening 
also affects CRC incidence, and the interaction between the increased potential exposure to 
risk factors as well as screening upon immigration to the United States is likely to be 
complex. Among Asians, neighborhood characteristics, including SES and ethnic enclave 
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status (as a measure of acculturation) may affect CRC incidence through housing density, 
built environment for physical activity, access to health care and cancer screening, food 
environment and diet, and cultural and community attitudes, and social norms about risk 
factors such as obesity (38–41).
In the United States, overall CRC incidence has been declining, consistent with our 
observations among non-Hispanic Whites in California. These declines may be attributable 
in part to screening (4,10,11). Some Asian groups are less likely to undergo screening, with 
barriers attributable to language, cultural, and access factors (42–47). One might hypothesize 
that the absence of declines in CRC incidence among most Asian groups in California 
during our study period may relate in part to relatively low screening uptake. A recent study 
focusing on the period 1988–2007 in California found decreases in CRC incidence over time 
among some Asian subgroups, but increases among others (48). The apparent higher 
prevalence of proximal CRC in non-Hispanic Whites compared with Asians might reflect a 
preferential reduction in distal CRC attributable to screening in non-Hispanic Whites (7–
9,49,50).
We are not aware of previous studies examining differences in CRC incidence with respect 
to nativity, SES, and residence in ethnic enclaves among Asians in the United States. For 
other cancers, differences related to nativity vary across Asian ethnic groups, as we observed 
here for CRC, and cancer incidence tends to track with lower SES and lower ethnic enclave 
neighborhoods (19–22). We have observed higher breast cancer rates among US-born 
compared with foreign-born Chinese and Filipino women, but similar rates between US-
born and foreign-born Japanese women, which may reflect relatively recent changes in risk 
factors in Japan, as well as high levels of acculturation among foreign-born Japanese-
Americans, who tend to have lived longer in the United States than other foreign-born 
Asian-Americans (14,27,51–53). As with breast cancer, our results for CRC among Japanese 
differed from the incidence patterns for most other Asian-American subgroups. CRC rates in 
Japanese-Americans suggest possible interactions between biological and environmental 
factors, given that CRC rates in Japanese migrants to the United States surpass those of 
Whites in a single generation (54).
Our analysis has notable strengths. It is based on 16 years of high-quality population-based 
cancer registry data from California, which includes more than half of the SEER Asian 
population (52), enhanced with the capability to examine rates by nativity and neighborhood 
characteristics. We capitalized on this large Asian-American population in California. We 
consider the ethnic and birthplace classifications to have low probabilities of 
misclassification or bias. Specifically, Asian ethnic group classification is coded directly 
from registry records (usually medical records) in most cases or by applying a validated 
algorithm (55). Cancer registry classification of specific Asian ethnicity shows good 
agreement with self-report (56). We have demonstrated that the completeness of registry 
information on birthplace is biased, with US-born more likely to be listed as unknown 
(24,25); thus, prior results that impute nativity based on a proportional distribution should be 
interpreted with caution (34). For cases with birthplace information reported to the registry 
(the vast majority), we have demonstrated that for Asians this shows excellent agreement 
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with self-report (24,57); for the remaining cases, we applied a validated algorithm with good 
sensitivity and specificity.
Our study has limitations. The sample sizes for US-born Koreans, Vietnamese, and South 
Asians were too small to be analyzed. Small case and denominator counts in other 
subgroups may have resulted in unstable rates and limited our ability to detect significant 
trends, as evidenced by some wide CIs for some annual percentage changes, such as the 
results for US-born Filipinos. Cancer registry data lack detail regarding potentially important 
clinical information, such as tumor markers, parental race/ethnicity, and individual-level 
education; other measures of SES, screening, and medical history; and other potential risk 
factors. The potential misclassifications with the nativity assignment algorithm could have 
affected our results, but given that the algorithm was applied to only 16% of the cases, it is 
unlikely to have affected our conclusions. It would be informative to examine cancer 
incidence in foreign-born Japanese stratified by time of residence in the United States in 
order to gain insight into the timing of acquired risk. Unfortunately, data on time of 
residence are not available. However, we have looked at the age at issue of the SSN, which 
may be a reasonable proxy of age at immigration. The mean sex-specific ages at issuance of 
SSN among foreign-born Japanese were 9–16 years younger than those of other foreign-
born Asian groups, suggesting that the foreign-born Japanese immigrated earlier in life, and 
thus may be more acculturated than other foreign-born Asians. Finally, there may be errors 
associated with the inter- and post-censal annual population estimates, which is a concern 
for the extrapolated estimates after year 2000 (58). Therefore, we limited our trend 
assessment through 2004.
In conclusion, we observed substantial differences in CRC incidence rates across Asian-
American subgroups. The significant impacts of nativity and residence in an ethnic enclave 
on CRC incidence suggest a substantial effect of acquired environmental factors. Disparities 
in screening rates in Asians compared with non-Hispanic Whites in the United States may 
explain, in part, the absence of declines in CRC incidence rates among most Asians during 
our study period, the higher prevalence of distal CRC among Asians, and the lower 
prevalence of localized CRC among foreign-born Asians. It remains to be determined 
whether our findings can inform tailored CRC control strategies in specific populations.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ Heritable and environmental factors contribute to differences in colorectal 
cancer (CRC) incidence between countries and subpopulations.
✓ Persons of Asian ancestry in the United States are a heterogenous population.
✓ Few subgroup-specific data are available on CRC incidence and mortality 
among foreign-born and US-born persons of Asian ancestry in the United 
States.
WHAT IS NEW HERE
✓ There are substantial differences in CRC incidence among Asian subgroups 
in California, with a threefold higher CRC incidence in foreign-born 
Japanese than in foreign-born South Asians.
✓ Compared with non-Hispanic Whites, all Asian subgroups except Japanese 
and US-born Chinese men had lower CRC incidence.
✓ Residence in an ethnic enclave was directly associated with decreased CRC 
incidence.
✓ The significant associations between CRC incidence and nativity and 
residence in an ethnic enclave on CRC incidence suggest a substantial effect 
of acquired environmental factors.
✓ In contrast with temporal trends among non-Hispanic Whites, CRC incidence 
did not decline significantly over time among most Asian subgroups during 
our study period.
✓ These contrasting trends may relate, in part, to disparities in screening rates 
in Asians compared with non-Hispanic Whites in the United States.
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Figure 1. 
Age-adjusted colorectal cancer (CRC) incidence trends for US- born Asian subgroups and 
non-Hispanic Whites in California. In the study period, overall CRC incidence was 
comparable in US-born Japanese and Chinese, and lower in US-born Filipino, than in non-
Hispanic Whites.
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Figure 2. 
Age-adjusted colorectal cancer (CRC) incidence trends for foreign-born Asian subgroups 
and non-Hispanic Whites in California. In the study period, overall CRC incidence was 
higher in foreign-born Japanese and lower in other foreign-born Asian subgroups than in 
non-Hispanic Whites.
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